Results 251 to 260 of about 9,310 (270)

Proteolytic activity in ristocetin preparations

Thrombosis Research, 1974
F.J. Morgan, Anna Goh, B.G. Firkin
openaire   +1 more source

Performance evaluation and multicentre study of a von Willebrand factor activity assay based on GPIb binding in the absence of ristocetin

Blood Coagulation and Fibrinolysis, 2014
exaly  

Bacterial sensitivity to ristocetin.

Antibiotics & chemotherapy (Northfield, Ill.), 2014
S S, SCHNEIERSON, D, AMSTERDAM, M S, BRYER   +2 more
openaire   +1 more source

Noncovalent Interactions:  Defining Cooperativity. Ligand Binding Aided by Reduced Dynamic Behavior of Receptors. Binding of Bacterial Cell Wall Analogues to Ristocetin A

Journal of the American Chemical Society, 2004
exaly  

Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function

Journal of Thrombosis and Haemostasis, 2009
exaly  

[Antibacterial activity of ristocetin].

La Riforma medica, 2000
A, FARULLA, A, CASSANO, L, NUZZOLO, G, GIORDANO   +3 more
openaire   +1 more source

Polymyxins, Colistin, Bacitracin, Ristocetin and Vancomycin

Pediatric Clinics of North America, 1968
openaire   +2 more sources

COMPLICATIONS OF RISTOCETIN THERAPY

The Lancet, 1958
openaire   +1 more source

Efficacy and Safety of the Factor VIII/von Willebrand Factor Concentrate, Haemate-P/Humate-P: Ristocetin Cofactor Unit Dosing in Patients with von Willebrand Disease

Thrombosis and Haemostasis, 2002
exaly  

Ristocetin: a clinical trial.

Canadian Medical Association journal, 2000
C E, VAN ROOYEN, A J, MACLEOD, G, EMBREE
openaire   +1 more source